Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
HB27 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 2 0
P17 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 3 0
FC05 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 2 0
H014 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021 3 0
Amantadine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/27/2021 2 0
Aloxistatin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021 2 0
Berzosertib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 2 0
RBD immunogen Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021 2 0